Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 3 boards, counting each seat separately. Longest: Q32 Bio Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Q32 Bio Inc. June 14, 202392.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 1, 2026 | Boundless Bio Inc. | Option exercise | +16,000 | $1.03 | $16,480 |
| Jul 1, 2026 | Takeda Pharmaceutical Company Limited | Grant or award | +3,800 | — | — |
| Jul 1, 2026 | Boundless Bio Inc. | Open-market sale | −16,000 | $2.49 | $39,840 |
| Aug 1, 2025 | Prime Medicine Inc. | Open-market purchase | +3,030,300 | $3.30 | $9,999,990 |
| Apr 2, 2024 | Boundless Bio Inc. | Derivative conversion | +589,743 | — | — |
| Apr 2, 2024 | Boundless Bio Inc. | Derivative conversion | +787,545 | — | — |
| Apr 2, 2024 | Boundless Bio Inc. | Derivative conversion | +1,048,433 | — | — |
| Apr 2, 2024 | Boundless Bio Inc. | Open-market purchase | +66,667 | $16.00 | $1,066,672 |
| Apr 2, 2024 | Boundless Bio Inc. | Open-market purchase | +133,333 | $16.00 | $2,133,328 |
Questions about Steven Gillis
What boards is Steven Gillis on?
Steven Gillis sits on the boards of Kardigan Inc., Q32 Bio Inc. and Takeda Pharmaceutical Company Limited.
How long has Steven Gillis served on boards?
Our records show at least 5 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.